Regenerative Medical Technology (RMTG) Long-Term Deferred Tax (2017 - 2023)
Regenerative Medical Technology (RMTG) posted quarterly Long-Term Deferred Tax of $5.3 million for Q4 2023, up 19.69% year-over-year from $4.4 million in Q4 2022, and up 19.69% quarter-over-quarter from $4.4 million in Q4 2022.
Regenerative Medical Technology (RMTG) Long-Term Deferred Tax (2017 - 2023) Analysis & Trends
Regenerative Medical Technology's Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $5.3 million for Q4 2023.
- In Q4 2023, Long-Term Deferred Tax rose 19.69% year-over-year to $5.3 million; the TTM figure through Dec 2023 stood at $5.3 million (up 19.69% YoY), while the FY2023 annual figure was $5.3 million, up 19.69% from the prior year.
- Long-Term Deferred Tax for Q4 2023 stood at $5.3 million, up from $4.4 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $5.3 million in Q4 2023, with the low at $1.3 million in Q4 2020.
- The 4-year median for Long-Term Deferred Tax is $4.0 million (2021), against an average of $3.6 million.
- The sharpest annual moves came in 2021 and 2023: Long-Term Deferred Tax surged 187.45% in 2021, then advanced 19.69% in 2023.
- Regenerative Medical Technology's Long-Term Deferred Tax stood at $1.3 million in 2020, then soared by 187.45% to $3.6 million in 2021, then rose by 22.18% to $4.4 million in 2022, then advanced by 19.69% to $5.3 million in 2023.
- Business Quant data shows RMTG's Long-Term Deferred Tax at $5.3 million in Q4 2023, $4.4 million in Q4 2022, and $3.6 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.29 Mn |
| Dec 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 3.62 Mn |
| Dec 31, 2020 | 1.26 Mn |
| Dec 31, 2018 | 813,814.00 |
| Dec 31, 2017 | 635,057.00 |